Gonorrhea Figures
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
Figure 13. Gonorrhea — Rates: United States, 1941–2008
Figure 14. Gonorrhea — Rates: Total and by sex: United States, 1989–2008
Figure 15. Gonorrhea — Rates by region: United States, 1999–2008
Figure 16. Gonorrhea — Rates by state: United States and outlying areas, 2008
Figure 17. Gonorrhea — Rates by county: United States, 2008
Figure 18. Gonorrhea — Age- and sex-specific rates: United States, 2008
Figure 19. Gonorrhea — Age-specific rates among women 15 to 44 years of age: United States, 1999–2008
Figure 20. Gonorrhea — Age-specific rates among men 15 to 44 years of age: United States, 1999–2008
Figure 21. Gonorrhea — Rates by race/ethnicity: United States, 1999–2008
Figure 22. Gonorrhea — Cases by reporting source and sex: United States, 1999–2008
Figure 23. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2008
Figure 24. Location of participating sentinel sites and regional laboratories in the United States, 2008
Figure 25. Gonococcal Isolate Surveillance Project (GISP) — Distribution of MICs to ceftriaxone among GISP isolates, 2004–2008
Figure 26. Distribution of MICs to azithromycin among GISP isolates, 2004–2008
Figure 27. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2008
Figure 28. Gonococcal Isolate Surveillance Project (GISP) — Penicillin, tetracycline, and ciprofloxacin resistance among GISP isolates, 2008
Figure 29. Gonococcal Isolate Surveillance Project (GISP) — Drugs used to treat gonorrhea in GISP patients, 1988–2008
- Page last reviewed: November 16, 2009 (archived document)
- Content source: